Publications by authors named "Mo-bin Wan"

Claim this Profile
Q
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.
Feng-Qin Hou, Liu-Wei Song, Quan Yuan, Lin-Lin Fang, Sheng-Xiang Ge, Mao-Rong Wang, Mo-Bin Wan, Gui-Qiang Wang

Theranostics· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients.
Ji-Dong Jia, Jin-Lin Hou, You-Kuan Yin, De-Ming Tan, Daozhen Xu, Yu-Ming Wang, Mo-Bin Wan, Qin-Huan Wang

Hepatol Int· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert recommendations on the application of interferon for chronic hepatitis B.
Mo Bin Wan, Xin Hua Weng

J Dig Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.
Liang Xue-Song, Li Cheng-Zhong, Zhou Ying, Wan Mo-Bin

BMC Gastroenterol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapy for chronic hepatitis B: can we reject combination therapy].
Mo-bin Wan

Zhonghua Gan Zang Bing Za Zhi· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Optimal therapy for chronic hepatitis B patients].
Mo-Bin Wan

Zhonghua Gan Zang Bing Za Zhi· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.
Edward J Gane, Yuming Wang, Yun-Fan Liaw, Jinlin Hou, Satawat Thongsawat, MoBin Wan

Liver Int· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The study on frequency distribution of regulatory T cells and its functional markers in peripheral blood of chronic hepatitis B].
Chen Li, Shao-jun Xing, Xue-zhang Duan, Mo-bin Wan, Hui-fen Wang

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The present situation and pondering on antiviral therapy in patients with decompensated cirrhosis].
Mo-Bin Wan

Zhonghua Gan Zang Bing Za Zhi· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells.
Xue-Song Liang, Ying Zhou, Chen-Zhong Li, Mo-Bin Wan

World J Gastroenterol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy.
Li Chen, Qian Zhang, De-min Yu, Mo-bin Wan, Xin-xin Zhang

J Hepatol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The importance of personalized optimal therapy for chronic hepatitis B patients].
Mo-bin Wan

Zhonghua Gan Zang Bing Za Zhi· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comparison of immune responses induced by recombinant attenuated Salmonella typhi carrying eukaryotic expression plasmid or prokaryotic expression plasmid of HCV core protein].
Zhi-Hui Chen, Ping Zhao, Shu-Mei Wu, Jie Cao, Bin Zhang, Mo-Bin Wan

Sheng Wu Gong Cheng Xue Bao· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].
Ji-dong Jia, Jin-lin Hou, You-kuan Yin, Dao-zhen Xu, De-ming Tan, Yu-ming Wang, Mo-bin Wan, Qin-huan Wang

Zhonghua Gan Zang Bing Za Zhi· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.
Hong Zhao, Fuat Kurbanov, Mo-Bin Wan, You-Kuan Yin, Jun-Qi Niu, Gui-Qiang Wang

Clin Infect Dis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mutation incidence of and resistant sites in HBV after long-term nucleoside analogs therapy].
Xue-song Liang, Mo-bin Wan

Zhonghua Gan Zang Bing Za Zhi· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].
Hong Zhao, Chong-wen Si, Lai Wei, Mo-bin Wan, You-kuan Ying

Zhonghua Gan Zang Bing Za Zhi· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model.
Min-De Zeng, Lun-Gen Lu, Yi-Min Mao, De-Kai Qiu, Ji-Qiang Li, Mo-Bin Wan, Ji-Yao Wang

Hepatology· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.
Ping Liu, Yi-Yang Hu, Cheng Liu, Lie-Ming Xu, Cheng-Hai Liu, Mo-Bin Wan

World J Gastroenterol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic and preventive activities of lamivudine on HBV re-activation in HBV carriers with immunodeficiency].
Xue-song Liang, Mo-bin Wan, Ji-xiu Chen, Cheng-zhong Li, Yu Song

Zhonghua Gan Zang Bing Za Zhi· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic effect of Bushen Rougan Recipe on hepatic fibrosis in rats].
Bin Zhang, Mo-Bin Wan, Ling-Tai Wang

Zhong Xi Yi Jie He Xue Bao· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.
Yi-Min Mao, Min-De Zeng, Lun-Gen Lu, Mo-Bin Wan, Cheng-Zhong Li, Ji-Yao Wang, Hui Wang

World J Gastroenterol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial].
Lun-gen Lu, Min-de Zeng, Yi-min Mao, Mo-bin Wan, Cheng-zhong Li, Ji-yao Wang, Hiu Wang

Zhonghua Gan Zang Bing Za Zhi· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Expression of TIMP-1 and TGF-beta1 mRNA in hepatic fibrosis rats and the therapeutic effects of Bushen Rougan Recipe].
Bin Zhang, Mo-Bin Wan, Lin-Tai Wang

Zhong Xi Yi Jie He Xue Bao· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
Ping Liu, Yi-Yang Hu, Cheng Liu, Lie-Ming Xu, Cheng-Hai Liu, Mo-Bin Wan

Zhong Xi Yi Jie He Xue Bao· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis